medtronic (1).jpg
Regulatory & QualityMedtronic Nabs FDA nod for Onyx Frontier, Resolute Onyx DESs to Treat Bifurcation LesionsMedtronic Nabs FDA nod for Onyx Frontier, Resolute Onyx DESs to Treat Bifurcation Lesions
The approval expands the company’s ability to treat the challenging coronary lesion and improve patient outcomes.
Sign up for the QMED & MD+DI Daily newsletter.